Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors

Hemasphere. 2025 Nov 25;9(11):e70256. doi: 10.1002/hem3.70256. eCollection 2025 Nov.
No abstract available

Publication types

  • Letter